General Information of Drug Transporter (DT)
DT ID DTD0255 Transporter Info
Gene Name SLC2A13
Transporter Name Proton myo-inositol cotransporter
Gene ID
114134
UniProt ID
Q96QE2

Transcriptional Regulation of This DT (TSR)

TF Superclass 1: Basic domains

      Class 1.1: Basic leucine zipper factors

Click to Show/Hide the Full List of 3 TF(s) Regulating This DT

        ATF3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [1]

TF Protein Name

Cyclic AMP-dependent transcription factor ATF-3 Transcription Factor Info

Tissue

Bone marrow; Colon; Embryo; Liver

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

        CREB1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [2]

TF Protein Name

Cyclic AMP-responsive element-binding protein 1 Transcription Factor Info

Tissue

Liver

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

        mutated NFE2L2 (rs17458086) 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A13 gene in pancreatic cancer condition [3]

TF Protein Name

Nuclear factor erythroid 2-related factor 2 Transcription Factor Info

Studied Phenotype

Pancreatic cancer [ICD11: 2C10]

Tissue

Pancreas

Related DT Changes

Up regulating

Experimental Material

human pancreatic cancer cell isolates

Detailed Description

mutated Nuclear factor erythroid 2-related factor 2 (mutated NFE2L2 (rs17458086)) has been reported to activate the transcription of SLC2A13 gene in pancreatic cancer condition, which leads to an increased expression of the drug transporter Proton myo-inositol cotransporter.

TF Superclass 2: Zinc-coordinating DNA-binding domains

      Class 2.2: Other C4 zinc finger-type factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        GATA1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [2]

TF Protein Name

Erythroid transcription factor Transcription Factor Info

Tissue

Blood; Bone marrow

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Erythroid transcription factor (GATA1) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

        GATA3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [4]

TF Protein Name

Trans-acting T-cell-specific transcription factor GATA-3 Transcription Factor Info

Tissue

Blood; Breast

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

      Class 2.3: C2H2 zinc finger factors

Click to Show/Hide the Full List of 3 TF(s) Regulating This DT

        CTCF 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [1]

TF Protein Name

Transcriptional repressor CTCF Transcription Factor Info

Tissue

Brain

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcriptional repressor CTCF (CTCF) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

        KLF4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [5]

TF Protein Name

Krueppel-like factor 4 Transcription Factor Info

Tissue

Pancreatic ductal; Skin

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Krueppel-like factor 4 (KLF4) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

        MAZ 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [1]

TF Protein Name

Myc-associated zinc finger protein Transcription Factor Info

Tissue

Blood; Bone marrow; Cervix; Liver; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Myc-associated zinc finger protein (MAZ) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

TF Superclass 3: Helix-turn-helix domains

      Class 3.3: Fork head / winged helix factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        E2F1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [4]

TF Protein Name

Transcription factor E2F1 Transcription Factor Info

Tissue

Mesenchymal

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor E2F1 (E2F1) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

        FOXA2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [2]

TF Protein Name

Hepatocyte nuclear factor 3-beta Transcription Factor Info

Tissue

Embryo; Liver; Lung; Skin

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

      Class 3.5: Tryptophan cluster factors

Click to Show/Hide the Full List of 4 TF(s) Regulating This DT

        ERG 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [5]

TF Protein Name

Transcriptional regulator ERG Transcription Factor Info

Tissue

Aorta

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcriptional regulator ERG (ERG) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

        ETS1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [1]

TF Protein Name

Protein C-ets-1 Transcription Factor Info

Tissue

Blood; Bone; Bone marrow; Kidney; Vein

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Protein C-ets-1 (ETS1) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

        FLI1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [4]

TF Protein Name

Friend leukemia integration 1 transcription factor Transcription Factor Info

Tissue

Blood; Mesenchymal; Vein

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.

        GABPA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A13 gene [5]

TF Protein Name

GA-binding protein alpha chain Transcription Factor Info

Tissue

Cervix; Liver; Mesenchymal

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

GA-binding protein alpha chain (GABPA) can directly bind to the SLC2A13 gene, which in turn affects the expression or function of the drug transporter Proton myo-inositol cotransporter.
References
1 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-328. (ID:ENSG00000151229)
2 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(D1):D991-5.
3 Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk. Cancer Sci. 2019 Jun;110(6):2022-2032.
4 Closure of the NCBI SRA and implications for the long-term future of genomics data storage. Genome Biol. 2011;12(3):402.
5 The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.